Evaluation of Treatment Response With Integrated MRI/PET in Patients With Hepatocellular Carcinoma
NCT02550613
·
clinicaltrials.gov ↗
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
DEVICE:
The imaging biomarkers determined by MR-PET
Sponsor
National Taiwan University Hospital